Brief review
New oral anticoagulants in patients with chronic kidney disease
Nuevos anticoagulantes orales en pacientes con enfermedad renal crónica
Lara Belmar Vega
, Ángel Luis Martín de Francisco, Jairo Bada da Silva, Luis Galván Espinoza, Gema Fernández Fresnedo
Corresponding author
Servicio de Nefrología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
Read
21182
Timeswas read the article
5488
Total PDF
15694
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 154 | 258 | 412 |
| 2025 5 | 242 | 65 | 307 |
| 2025 4 | 217 | 31 | 248 |
| 2025 3 | 265 | 75 | 340 |
| 2025 2 | 187 | 49 | 236 |
| 2025 1 | 143 | 32 | 175 |
| 2024 12 | 123 | 30 | 153 |
| 2024 11 | 128 | 36 | 164 |
| 2024 10 | 127 | 68 | 195 |
| 2024 9 | 145 | 49 | 194 |
| 2024 8 | 127 | 78 | 205 |
| 2024 7 | 97 | 33 | 130 |
| 2024 6 | 105 | 44 | 149 |
| 2024 5 | 121 | 47 | 168 |
| 2024 4 | 100 | 38 | 138 |
| 2024 3 | 91 | 30 | 121 |
| 2024 2 | 56 | 30 | 86 |
| 2024 1 | 45 | 33 | 78 |
| 2023 12 | 40 | 26 | 66 |
| 2023 11 | 89 | 40 | 129 |
| 2023 10 | 109 | 43 | 152 |
| 2023 9 | 202 | 29 | 231 |
| 2023 8 | 98 | 38 | 136 |
| 2023 7 | 95 | 32 | 127 |
| 2023 6 | 79 | 26 | 105 |
| 2023 5 | 115 | 163 | 278 |
| 2023 4 | 71 | 19 | 90 |
| 2023 3 | 114 | 35 | 149 |
| 2023 2 | 111 | 21 | 132 |
| 2023 1 | 142 | 33 | 175 |
| 2022 12 | 105 | 38 | 143 |
| 2022 11 | 84 | 47 | 131 |
| 2022 10 | 113 | 53 | 166 |
| 2022 9 | 81 | 45 | 126 |
| 2022 8 | 105 | 63 | 168 |
| 2022 7 | 85 | 47 | 132 |
| 2022 6 | 98 | 54 | 152 |
| 2022 5 | 135 | 31 | 166 |
| 2022 4 | 154 | 74 | 228 |
| 2022 3 | 160 | 71 | 231 |
| 2022 2 | 199 | 60 | 259 |
| 2022 1 | 232 | 55 | 287 |
| 2021 12 | 143 | 48 | 191 |
| 2021 11 | 145 | 34 | 179 |
| 2021 10 | 191 | 85 | 276 |
| 2021 9 | 178 | 56 | 234 |
| 2021 8 | 158 | 69 | 227 |
| 2021 7 | 148 | 55 | 203 |
| 2021 6 | 97 | 66 | 163 |
| 2021 5 | 135 | 76 | 211 |
| 2021 4 | 391 | 143 | 534 |
| 2021 3 | 248 | 91 | 339 |
| 2021 2 | 198 | 114 | 312 |
| 2021 1 | 171 | 58 | 229 |
| 2020 12 | 140 | 42 | 182 |
| 2020 11 | 155 | 51 | 206 |
| 2020 10 | 98 | 47 | 145 |
| 2020 9 | 134 | 41 | 175 |
| 2020 8 | 157 | 35 | 192 |
| 2020 7 | 191 | 36 | 227 |
| 2020 6 | 204 | 57 | 261 |
| 2020 5 | 201 | 53 | 254 |
| 2020 4 | 194 | 54 | 248 |
| 2020 3 | 281 | 73 | 354 |
| 2020 2 | 249 | 69 | 318 |
| 2020 1 | 373 | 102 | 475 |
| 2019 12 | 218 | 120 | 338 |
| 2019 11 | 288 | 144 | 432 |
| 2019 10 | 256 | 85 | 341 |
| 2019 9 | 295 | 168 | 463 |
| 2019 8 | 139 | 104 | 243 |
| 2019 7 | 184 | 91 | 275 |
| 2019 6 | 411 | 123 | 534 |
| 2019 5 | 114 | 81 | 195 |
| 2019 4 | 143 | 123 | 266 |
| 2019 3 | 57 | 67 | 124 |
| 2019 2 | 35 | 43 | 78 |
| 2019 1 | 34 | 51 | 85 |
| 2018 12 | 415 | 75 | 490 |
| 2018 11 | 792 | 57 | 849 |
| 2018 10 | 697 | 46 | 743 |
| 2018 9 | 178 | 52 | 230 |
| 2018 8 | 68 | 50 | 118 |
| 2018 7 | 73 | 37 | 110 |
| 2018 6 | 90 | 33 | 123 |
| 2018 5 | 158 | 44 | 202 |
| 2018 4 | 201 | 34 | 235 |
| 2018 3 | 105 | 12 | 117 |
| 2018 2 | 243 | 7 | 250 |
| 2018 1 | 52 | 14 | 66 |
| 2017 12 | 220 | 19 | 239 |
| 2017 11 | 69 | 22 | 91 |
| 2017 10 | 54 | 9 | 63 |
| 2017 9 | 53 | 15 | 68 |
| 2017 8 | 54 | 16 | 70 |
| 2017 7 | 59 | 11 | 70 |
| 2017 6 | 51 | 8 | 59 |
| 2017 5 | 19 | 3 | 22 |
Show all
